Imogen Mitchell - Morphing the Recalcitrant ClinicianSMACC Conference
Imogen Mitchell’s SMACC Chicago talk 'Morphing the Recalcitrant Clinician’ talks us through the steps to engage the reluctant physician when implementing change.
Imogen initally touches on the stages of physician engagement from aversion, to apathy, to engaged and then outlines the steps to morphing the reluctant physician.
1. Seek out a clinical champion
2. Establish a common purpose/vision
3. Standardise what is standardisable
4. Communication, communication, communication
5. Work out barriers and overcome them
6. Deal with the ‘Whats in it for me?’WIFM
Physical Therapy in the Emergency Departmentchristaloyd
At the Heart of the Rockies Regional Medical Center in Salida, CO, I got the opportunity to take the lead on doing research and analyzing data to create a presentation describing the benefits of Physical Therapy in an emergency department.
Jintronix : projet TI novateurs en prévention du vieillissement / Monsieur David Schacter - Chief Operating Officer, Jintronix - présentation 10 octobre dans le cadre de la grande conférence métropoline le FUTUR DE LA SANTÉ : innovez pour une population connectée.
Imogen Mitchell - Morphing the Recalcitrant ClinicianSMACC Conference
Imogen Mitchell’s SMACC Chicago talk 'Morphing the Recalcitrant Clinician’ talks us through the steps to engage the reluctant physician when implementing change.
Imogen initally touches on the stages of physician engagement from aversion, to apathy, to engaged and then outlines the steps to morphing the reluctant physician.
1. Seek out a clinical champion
2. Establish a common purpose/vision
3. Standardise what is standardisable
4. Communication, communication, communication
5. Work out barriers and overcome them
6. Deal with the ‘Whats in it for me?’WIFM
Physical Therapy in the Emergency Departmentchristaloyd
At the Heart of the Rockies Regional Medical Center in Salida, CO, I got the opportunity to take the lead on doing research and analyzing data to create a presentation describing the benefits of Physical Therapy in an emergency department.
Jintronix : projet TI novateurs en prévention du vieillissement / Monsieur David Schacter - Chief Operating Officer, Jintronix - présentation 10 octobre dans le cadre de la grande conférence métropoline le FUTUR DE LA SANTÉ : innovez pour une population connectée.
Poster: Audit of Appropriateness for Brain Scan Use for Paediatric Headache a...Lyndon Woytuck
The purpose is to evaluate practice variation at the emergency department in comparison with best practice for brain imaging in children presenting with headache. The results of the study might be used to inform a clinical prediction rule in order to better stratify risk according to the American College of Radiology Appropriateness Criteria.
I created a poster for presentation and am currently working on a paper for publication in a scholarly journal.
What if medicine understood itself as an information processing disciplineIsaac Kohane
What are the obstacles to progress because medicine does not understand itself as a knowledge processing discipline? What are dangers of a medicine-naive data science? What are the leveraged paths forward?
Considering the fast-developing technologies of the past 50 years, is it possible that a computer replaces human beings to heal humanity in the future?
Poster: Audit of Appropriateness for Brain Scan Use for Paediatric Headache a...Lyndon Woytuck
The purpose is to evaluate practice variation at the emergency department in comparison with best practice for brain imaging in children presenting with headache. The results of the study might be used to inform a clinical prediction rule in order to better stratify risk according to the American College of Radiology Appropriateness Criteria.
I created a poster for presentation and am currently working on a paper for publication in a scholarly journal.
What if medicine understood itself as an information processing disciplineIsaac Kohane
What are the obstacles to progress because medicine does not understand itself as a knowledge processing discipline? What are dangers of a medicine-naive data science? What are the leveraged paths forward?
Considering the fast-developing technologies of the past 50 years, is it possible that a computer replaces human beings to heal humanity in the future?
How to Think Straight- Cognitive Debiasing Pat CroskerrySMACC Conference
"How to think straight: Cognitive de-biasing by Pat Croskerry
The number of preventable deaths of hospitalized patients in the US each year is estimated at 40,000- 80,000. The figure for the ICU alone is estimated at 40,000 so the death rate must be in the higher end of the range. When settings outside the hospital are taken into account (ED, primary care), the overall number must be considerably higher.
While many factors contribute to diagnostic failure, a variety of sources suggest that physician’s thinking has a lot to do with it. Dual Process Theory describes how the brain makes decisions in one of two modes: through fast, unconscious, intuitive processes (System 1) or through slower, conscious, analytical processes (System 2). Mental short-cuts (heuristics) and biases are predominantly located in the intuitive mode where we spend most of our conscious time, and this is where the majority of decision failures occur. Thinking straight essentially means achieving a good balance between System 1 and System 2 decision making, and much of our cognitive effort needs to go into monitoring what our unconscious brains are doing in System 1. This is referred to by a variety of terms: metacognition, reflection, mindfulness, and others. They all involve cognitive de-coupling from System 1 and characterize the process of cognitive de-biasing. This is not easily accomplished in the ED or any environment where decision density is often high, throughput pressure exists, resources may be limited, and where decision makers may be fatigued and/or sleep deprived.
While medicine has acquired a variety of strategies over the years for de-biasing clinicians, added benefits can be obtained by developing specific mindware to tackle particular biases. Clinicians need to be aware of the operating characteristics of the dual process model of decision making, of the prevalence and nature of biases, and of how to apply and sustain de-biasing mindware in their decision making.
"
MedicalResearch.com: Medical Research Interviews Month in ReviewMarie Benz MD FAAD
MedicalResearch.com powerpoint of exclusive interviews with medical researchers from NEJM, JAMA, BMJ, The Lancet and other major and specialty medical journals.
Personalized Medicine: Are we there yet?Reid Robison
Slides on the future of healthcare, entitled "Personalized Medicine: Are we there yet?" form a lecture given by Reid Robison, MD MBA at Brigham Young University in the College of Life Sciences in December 2014. The presentation covers the arrival of genome-guided precision medicine as well as the digital health movement and the shift towards a patient-centric, consumer-driven healthcare system.
Similar to Artificial Intelligence in Medicine that Counts (20)
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
5. DEPARTMENT OF
Biomedical Informatics
A common diagnosis becomes undiagnosed
• 3 years and 10 months old with bloody stool.
• Underwent endoscopy in November 2005 at 4 years old which showed a pancolitis.
• He was started on sulfasalazine; maintained on fish oil and sulfasalazine until age 13 ½ at which
point he flared. That was in July 2015.
• He’s been in a flare since. Unsuccessful wean from prednisone, vancomycin effect transient
• Started on 6MP in March 2016 with no effect over 3 months despite therapeutic levels.
• Started on infliximab 5mg/kg 7/6/2016 with no effect.
• Aug 20th tried a course of Rifaximin with initial, temporally related, transient improvement.
• Has tried multiple forms of PR meds with no effect, including cortisone enemas, cortifoam,
canasa suppos. .
• In September 2016, stool turned bloody and frequency was hourly, hospitalized for tacrolimus
• which improved symptoms but did not produce a remission.
• Vedolizumab was added in October with no appreciable effect.
6. DEPARTMENT OF
Biomedical Informatics
Boundary between diseased and
healthy patients
Can we identify an existing drug that
will move these patients towards the
healthy region?
IBD Expression Profiles:
Whole Blood
8. DEPARTMENT OF
Biomedical Informatics
Best ranked compound for our patient
• Indirubin
• Chemical compound
most often produced
as a byproduct of
bacterial metabolism
• Constituent of indigo
naturalis (also known
as qing dai),
12. DEPARTMENT OF
Biomedical Informatics
When does Medicine succumb to AlphaZero?
• Deterministic.
• Fully observed.
• The action space is discrete.
• Access to a perfect simulator (the
game itself), so the effects of any
action are known exactly.
• Each episode/game is relatively short.
• Evaluation is clear, fast and allows a
lot of trial-and-error experience.
• Huge datasets of human play.
• NOT physiology
• NOT disease course
• NOT drug response
• NOT surgery
• So…. What might succumb…? Which
medical ‘game’ fits the criteria….?
• The game of reimbursement
• Has funded billions of $$ of EHR
• Of ontology wrangling companies etc
13. DEPARTMENT OF
Biomedical Informatics
Bias and fairness: AI applications in medicine
• GAN to maximize
reimbursement
• GAN to
minimize/maximize care
utilization
• Opaque biases in drug or
procedure
recommendations.
•At-will review/exploration
of doctor’s
decisions/advice
•Maximize patient’s utilities
in clinical decision-making
over all achievable
treatment plans
•Netflix for medicine
14. DEPARTMENT OF
Biomedical Informatics
AI -> $$$ <- Platform/Path/Payors
Electronic
Health
Record
Data
(labs, meds, images…)
Summary & Decisions
(Rx, Dx, Prognosis…)
$
Consumers
$Employers
$Government
`
16. DEPARTMENT OF
Biomedical Informatics
But at least we have a solid medical education
system…
16
If a test to detect a disease whose
prevalence is 1/1000 has a false positive
rate of 5%, what is the chance that a
person found to have a positive result
actually has the disease, assuming you
know nothing about the person's
symptoms or signs?
19. DEPARTMENT OF
Biomedical Informatics
• Who completes the loop?
• Who is trusted?
• Who integrates with rest of care?
• Who oversees
• Process automation?
• Who does expert catch?
• What do you have to show to get
$$$
21. DEPARTMENT OF
Biomedical Informatics
Reflections/Conclusion
• How would you like to spend your AI effort chits?
• Doing what doctors are supposed to do at expert level?
• Or by what they cannot do (MD super powers)?
• Most of the interesting part of medicine is not in classification or prediction
• It’s in making the right DECISION for precious human beings faced with suffering/death
• Unless you roll a new one, you have to understand THIS healthcare system
processes NOT just medicine art/science.
• Understanding the “job-to-be-done” and where the $$ coming from as important
as CS/AI +medical expertise.
• Doctors are not necessarily expert in this prioritization.
• Don’t lie, it makes us all look bad.
• YOU can roll a new health care system that is data and knowledge-driven.
22. DEPARTMENT OF
Biomedical Informatics
DATAPOWERED STRATEGIESTO
COUNTERANTIBIOTICRESISTANCE
Harvard Medical School
June 8th 2018
Join us for discussions on ‘omics’, health-services, and
internet data integration for innovation in diagnosis and
treatmentThank you
"On Oxford Steet in Cambridge, Mass. lives a sibyl, a priestess of science. Her devotees take their problems to her as devout ancient Greeks took their insolubles to Delphi. She is no mumbling, anonymous priestess, frothing her mouth with riddles. Her name is Bessie; she is a long, slim, glass-sided machine with 760.000 parts, and the riddles that are put to her and that she unfailingly answers concern such matters as rocket motors, nuclear physics and trigonometric functions". For a computing machine, Bessie is old: she has been steadily at work since 1944. And she is not the brightest of her breed. Compared to her children and grandchildren (one of whom, Harvard's Mark III lives on the floor below in Harvard's Computation Laboratory), she is dim-witted and slow. But Bessie is a progenetrix, a sort of mechanical Eve. By proving what computing machines could do, she started one of the liveliest developments of modern science. Some scientists think that Bessie's descendants will have more effect on Makind than atomic energy. Modern man has become accustomed to machines with superhuman muscles, but machines with superhuman brains are still a little frightening. The men who design them try to deny that they are creating their own intellectual competitors." ‒Time Magazine, January 23, 1950, p54.
Important, What can it avoid? Lots of stupidity. Missed diagnoses..
4
umor necrosis factor-α (TNFα) antagonists are effective for the treatment of inflammatory bowel diseases, demonstrating improvement in patients' quality of life, and reductions in surgeries and hospitalizations.1 However, around 10–30% of patients do not respond to the initial treatment and 23–46% of patients lose response over time. Determining whether the reason for failure is a primary or secondary non-response is paramount to successfully treat these patients. A significant proportion of patients do not respond (primary non-response—PNR) to TNFα antagonists. Distinct mechanisms underlie these two forms of TNFα antagonist treatment fail
Not noise
Not confounding
Signal
Different in China than US
Which game in medicine is a fully human artefact with interesting yet somewhat arbitrary rules?
Opaque biases a lot worse than the google image search problems
Instances on left much more $$$ in nesr term.
Where is the money?
3.3 trillion or $10,348 per person
17.9% of GDP
37% Fed
34% Private
11% Out of pocket
Hospital Care 32%
MD/clinical services 20% ($664.9B in 2016)
Prescrption drugs 10% $328B
Home healthcare 3% $93B
Who will be the beneficiary?
https://nccih.nih.gov/research/results/spotlight/americans-spend-billions $30B/year on alternative health